U-Neuron Biomedical Inc (TPEX:6973)
Taiwan · Delayed Price · Currency is TWD 32.70
-0.25 (-0.76%)
Jul 14, 2026, 1:25 PM CST
U-Neuron Biomedical Market Cap
U-Neuron Biomedical has a market cap or net worth of 973.67 million as of July 14, 2026. Its market cap has decreased by -4.91% in one year.
Market Cap
973.67M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
32.70
Market Cap Chart
Since July 20, 2023, U-Neuron Biomedical's market cap has decreased from 1.36B to 973.67M, a decrease of -28.37%. That is a compound annual growth rate of -10.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 973.67M | -13.06% |
| Dec 31, 2025 | 1.12B | -9.44% |
| Dec 31, 2024 | 1.24B | -30.25% |
| Dec 29, 2023 | 1.77B | 30.43% |
| Jul 20, 2023 | 1.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 1.18B |
| BiOptic | 1.16B |
| LabTurbo Biotech | 1.11B |
| Lukas Biomedical | 1.07B |
| Bio Preventive Medicine | 1.06B |
| Level Biotechnology | 1.03B |
| Holy Stone Healthcare | 1.02B |
| GeneReach Biotechnology | 979.88M |